PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.300
-0.110 (-7.80%)
At close: Oct 15, 2026, 4:00 PM EDT
1.344
+0.044 (3.40%)
After-hours: Oct 15, 2026, 7:58 PM EDT
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $94.22 million as of October 15, 2026. It is the 25,675th most valuable company in the world and the 4,147th biggest in the United States. Its market cap has increased by 116.18% in one year.
Market Cap
94.22M
Enterprise Value
92.98M
1-Year Change
116.18%
Global Rank
Country Rank
#4,147 United States
Category
ChartMarket Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has increased from $45.51M to $94.22M, an increase of 107.01%. That is a compound annual growth rate of 10.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 94.22M | 123.66% |
| Dec 31, 2025 | 42.12M | -30.92% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 99.53M |
| Cibus | 98.59M |
| PMV Pharmaceuticals | 97.41M |
| Polaryx Therapeutics | 97.20M |
| NeurAxis | 97.20M |
| Atara Biotherapeutics | 96.86M |
| Anixa Biosciences | 96.64M |
| Immunic | 96.60M |